Agnes Gebhard

1.7k total citations
20 papers, 377 citations indexed

About

Agnes Gebhard is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Agnes Gebhard has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Agnes Gebhard's work include Tuberculosis Research and Epidemiology (19 papers), Pneumonia and Respiratory Infections (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Agnes Gebhard is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Pneumonia and Respiratory Infections (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Agnes Gebhard collaborates with scholars based in Netherlands, United States and Vietnam. Agnes Gebhard's co-authors include Frank Cobelens, Martien W. Borgdorff, Susan van den Hof, Suzanne Verver, Willeke P. J. Franken, David Collins, Ernesto Jaramillo, Sandra V. Kik, Connie Erkens and Sandra M. Arend and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Agnes Gebhard

17 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnes Gebhard Netherlands 10 322 231 125 35 34 20 377
V. K. Arora India 10 323 1.0× 226 1.0× 124 1.0× 42 1.2× 37 1.1× 31 436
Stobdan Kalon South Africa 12 372 1.2× 273 1.2× 107 0.9× 56 1.6× 19 0.6× 17 457
Ejaz Qadeer Pakistan 10 267 0.8× 205 0.9× 78 0.6× 33 0.9× 29 0.9× 21 324
Phanindra Dewan India 12 336 1.0× 268 1.2× 89 0.7× 43 1.2× 57 1.7× 18 403
Mao Tan Eang Cambodia 12 368 1.1× 271 1.2× 83 0.7× 95 2.7× 67 2.0× 24 469
Nimalan Arinaminpathy United Kingdom 10 277 0.9× 171 0.7× 45 0.4× 30 0.9× 39 1.1× 23 376
Ramya Ananthakrishnan India 11 262 0.8× 171 0.7× 51 0.4× 41 1.2× 70 2.1× 24 305
Shibu Balakrishnan India 8 286 0.9× 233 1.0× 145 1.2× 25 0.7× 30 0.9× 28 369
Sriprapa Nateniyom Thailand 13 446 1.4× 375 1.6× 189 1.5× 37 1.1× 14 0.4× 24 539
Fukushi Morishita Philippines 12 405 1.3× 263 1.1× 79 0.6× 83 2.4× 78 2.3× 37 496

Countries citing papers authored by Agnes Gebhard

Since Specialization
Citations

This map shows the geographic impact of Agnes Gebhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes Gebhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes Gebhard more than expected).

Fields of papers citing papers by Agnes Gebhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes Gebhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes Gebhard. The network helps show where Agnes Gebhard may publish in the future.

Co-authorship network of co-authors of Agnes Gebhard

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes Gebhard. A scholar is included among the top collaborators of Agnes Gebhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes Gebhard. Agnes Gebhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reuter, Anja, Jonathan Stillo, Irene Motta, et al.. (2025). The time is now: making the case for compassionate use/pre-approval access to new TB drugs. PubMed. 2(12). 701–704.
2.
Wares, D. F., et al.. (2024). Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 36. 100472–100472.
3.
Jerene, Degu, et al.. (2024). Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review. SHILAP Revista de lepidopterología. 4(8). e0002885–e0002885. 1 indexed citations
4.
5.
Haas, Petra de, et al.. (2023). Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults. The International Journal of Tuberculosis and Lung Disease. 27(1). 19–27. 14 indexed citations
6.
Jerene, Degu, et al.. (2022). High rates of undiagnosed diabetes mellitus among patients with active tuberculosis in Addis Ababa, Ethiopia. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 27. 100306–100306. 4 indexed citations
7.
Jerene, Degu, Tewodros Haile, Ahmed Bedru, et al.. (2022). The yield of chest X-ray based versus symptom-based screening among patients with diabetes mellitus in public health facilities in Addis Ababa, Ethiopia. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 29. 100333–100333. 2 indexed citations
8.
Mulder, Christiaan, et al.. (2022). Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis. BMJ Global Health. 7(1). e007182–e007182. 22 indexed citations
9.
Anh, Le Thi Ngoc, Ajay Kumar, Gomathi Ramaswamy, et al.. (2020). High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam. Tropical Medicine and Infectious Disease. 5(1). 43–43. 10 indexed citations
10.
Basri, Chaerul, et al.. (2020). Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia. The International Journal of Tuberculosis and Lung Disease. 24(2). 250–257. 9 indexed citations
11.
Wares, D. F., Gunta Dravniece, Agnes Gebhard, et al.. (2020). Introducing bedaquiline: experiences from the Challenge TB Project. The International Journal of Tuberculosis and Lung Disease. 24(10). 1046–1053. 1 indexed citations
12.
Vries, Gèrard de, Svetla Tsolova, Laura Anderson, et al.. (2017). Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health. 17(1). 334–334. 17 indexed citations
13.
Surya, Asik, et al.. (2017). Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public–Private Collaboration. The Journal of Infectious Diseases. 216(suppl_7). S724–S732. 55 indexed citations
14.
Tiemersma, Edine, Nguyễn Văn Hùng, Nguyen Thi Le Thanh, et al.. (2016). Infection control and tuberculosis among health care workers in Viet Nam, 2009-2013: a cross-sectional survey. BMC Infectious Diseases. 16(1). 664–664. 9 indexed citations
15.
Mitnick, Carole D., Carly A. Rodriguez, Grania Brigden, et al.. (2016). Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda. PLoS ONE. 11(5). e0155968–e0155968. 22 indexed citations
16.
17.
Werf, Marieke J. van der, et al.. (2013). First joint meeting of three European tuberculosis networks. Eurosurveillance. 18(37).
18.
Nguyen, Hoa Binh, Edine Tiemersma, Dinh Ngoc Sy, et al.. (2011). Household expenditure and tuberculosis prevalence in VietNam: prediction by a set of household indicators.. PubMed. 15(1). 32–7. 25 indexed citations
19.
Kik, Sandra V., Willeke P. J. Franken, M. Mensen, et al.. (2009). Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. European Respiratory Journal. 35(6). 1346–1353. 110 indexed citations
20.
Anthony, Richard, Frank Cobelens, Agnes Gebhard, et al.. (2009). Liquid culture for Mycobacterium tuberculosis: proceed, but with caution.. PubMed. 13(9). 1051–3. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. K. Arora Breakdown of academic impact, for papers by Stobdan Kalon Breakdown of academic impact, for papers by Ejaz Qadeer Breakdown of academic impact, for papers by Phanindra Dewan Breakdown of academic impact, for papers by Mao Tan Eang Breakdown of academic impact, for papers by Nimalan Arinaminpathy Breakdown of academic impact, for papers by Ramya Ananthakrishnan Breakdown of academic impact, for papers by Shibu Balakrishnan Breakdown of academic impact, for papers by Sriprapa Nateniyom Breakdown of academic impact, for papers by Fukushi Morishita
Rankless by CCL
2026